EFFECT OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR ON SURVIVAL IN LETHALLY IRRADIATED MICE

被引：25
|
作者：
HOSOI, Y
KURISHITA, A
ONO, T
SAKAMOTO, K
机构：
[1] Departments of Radiation Research and Radiology, Tohoku University School of Medicine, Sendai
来源：
ACTA ONCOLOGICA | 1992年 / 31卷 / 01期
关键词：
RADIATION; TOTAL BODY; MICE; GRANULOCYTE; COLONY-STIMULATING FACTOR (G-CSF); SURVIVAL;
D O I：
10.3109/02841869209088267
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Repeated injections of recombinant human granulocyte colony-stimulating factor (rhG-CSF) to lethally irradiated mice increased the rate of animal survival. Dose modification factor was 1.20 when 4.5-mu-g/mouse of rhG-CSF was given daily for 14 days after whole body irradiation. Haematological examinations revealed that rhG-CSF increased the number of blood-circulating leukocytes, neutrophils, monocytes and erythrocytes, but not that of lymphocytes and thrombocytes. Spleen weight and number of endogenous spleen colonies were also increased by rhG-CSF treatment compared with the values for mice irradiated only.
引用
收藏
页码：59 / 63
页数：5
相关论文
共 50 条
  • [41] EFFECT OF HUMAN RECOMBINANT GRANULOCYTE COLONY-STIMULATING FACTOR ON HEMATOPOIETIC INJURY IN MICE INDUCED BY 5-FLUOROURACIL
    SHIMAMURA, M
    KOBAYASHI, Y
    YUO, A
    URABE, A
    OKABE, T
    KOMATSU, Y
    ITOH, S
    TAKAKU, F
    BLOOD, 1987, 69 (01) : 353 - 355
  • [42] Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility study
    GJ Veldhuis
    PHB Willemse
    JH Beijnen
    H Boonstra
    H Piersma
    WTA van der Graaf
    EGE de Vries
    British Journal of Cancer, 1997, 75 : 703 - 709
  • [43] Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: A feasibility study
    Veldhuis, GJ
    Willemse, PHB
    Beijnen, JH
    Boonstra, H
    Piersma, H
    vanderGraaf, WTA
    deVries, EGE
    BRITISH JOURNAL OF CANCER, 1997, 75 (05) : 703 - 709
  • [44] PROTECTIVE EFFECT OF HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR ON MICROBIAL INFECTION IN NEUTROPENIC MICE
    MATSUMOTO, M
    MATSUBARA, S
    MATSUNO, T
    TAMURA, M
    HATTORI, K
    NOMURA, H
    ONO, M
    YOKOTA, T
    INFECTION AND IMMUNITY, 1987, 55 (11) : 2715 - 2720
  • [45] Effect of recombinant human granulocyte/macrophage colony-stimulating factor on the healing of colonic anastomosis in rats
    Demirer, S
    Sengül, N
    Inan, A
    Eroglu, A
    Bumin, C
    Kuterdem, E
    JOURNAL OF INVESTIGATIVE SURGERY, 2001, 14 (04) : 221 - 225
  • [46] EFFECT OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR (RHG-CSF) ON CIRCULATING PLATELETS
    AVENARIUS, HJ
    FREUND, M
    DEINHARDT, J
    POLIWODA, H
    ANNALS OF HEMATOLOGY, 1992, 65 (01) : 6 - 9
  • [47] Activation of neutrophil function by recombinant human granulocyte colony-stimulating factor improves the survival of rats with peritonitis
    Ishikura, H
    Uedono, Y
    Yamagami, K
    Arai, T
    Takeyama, N
    Tanaka, T
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1996, 26 (09): : 694 - 699
  • [48] EFFECT OF RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR ON CHEMOTHERAPY-INDUCED MYELOSUPPRESSION
    ANTMAN, KS
    GRIFFIN, JD
    ELIAS, A
    SOCINSKI, MA
    RYAN, L
    CANNISTRA, SA
    OETTE, D
    WHITLEY, M
    FREI, E
    SCHNIPPER, LE
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (10): : 593 - 598
  • [49] EFFECT OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR IN PATIENTS RECEIVING CHEMOTHERAPY FOR UROGENITAL CANCER
    ASO, Y
    AKAZA, H
    JOURNAL OF UROLOGY, 1992, 147 (04): : 1060 - 1064
  • [50] Recombinant human granulocyte-macrophage colony-stimulating factor: effect of glycosylation on pharmacokinetic parameters
    Marini, Guillermo
    Forno, Guillermina
    Kratje, Ricardo
    Etcheverrigaray, Marina
    ELECTRONIC JOURNAL OF BIOTECHNOLOGY, 2007, 10 (02) : 271 - 278
12345